There is growing increase in the global prevalence of depression, but treatment outcome of this highly disabling disease is not satisfactory. Many patients are not benefitted by the currently prescribed antidepressants—together with this partial remission is very common. Improving treatment strategies and developing better therapeutic agents for treating depression is therefore highly needed. Stress-related epigenetic changes play a critical role in the pathogenesis as well as treatment of depression. Stressful events activate hypothalamic-pituitary-adrenal axis to increase circulating levels of glucocorticoids (GCs), and a greater sensitivity to this fright and flight response increases risk of depression. A role of serotonin (5-hydroxytryptamine; 5-HT) in responses to stress and in the pathogenesis and treatment of depression is well established. Substantial evidence supports a critical role of 5-HT1A receptors in these effects of 5-HT. The present article targets stress-induced higher and sustained increases of GCs and mediated influences on the physiological as well transcriptional regulation of 5-HT1A receptors to evaluate their causal role in the pathogenesis of depression. It is suggested that synthetic compounds with antagonist activity for GC receptors and agonist activity for 5-HT1A receptors may prove better therapeutic agents for treating depression.
BlierPPiñeyroGel MansariMBergeronRde MontignyC.1998. Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Ann N Y Acad Sci 1998;861:204–16.
6.
Borroto-EscuelaDONarváezMAmbroginiPFerraroLBritoIRomero-FernandezW, and others. 2018. Receptor-receptor interactions in multiple 5-HT1A heteroreceptor complexes in raphe-hippocampal 5-HT transmission and their relevance for depression and its treatment. Molecules23(6):1341.
7.
CannonWB. 1914. The emergency functions of adrenal medulla in pain and major emotions. Am J Physiol33:356–72.
8.
CaoCSuMZhouF.2017. Mangiferin inhibits hippocampal NLRP3 inflammasome and exerts antidepressant effects in a chronic mild stress mice model. Behav Pharmacol28(5):356–64.
9.
CiprianiAFurukawaTASalantiGChaimaniAAtkinsonLZOgawaY, and others. 2018. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet391(10128):1357–66.
10.
CirannaL. 2006. Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: implications in physiological functions and in pathology. Curr Neuropharmacol4(2):101–14.
11.
CoppenA. 1967. The biochemistry of affective disorders. Br J Psychiatry113(504):1237–64.
12.
de KloetERde KloetSFde KloetCSde KloetAD. 2019. Top-down and bottom-up control of stress-coping. J Neuroendocrinol31(3):e12675.
13.
de KloetERMeijerOCde NicolaAFde RijkRHJoëlsM.2018. Importance of the brain corticosteroid receptor balance in metaplasticity, cognitive performance and neuro-inflammation. Front Neuroendocrinol49:124–45.
14.
de KloetEROtteCKumstaRKokLHillegersMHHasselmannH, and others. 2016. Stress and depression: a crucial role of the mineralocorticoid receptor. Neuroendocrinology28(8). doi:10.1111/jne.12379
FarhanMIkramHKanwalSHaleemDJ. 2014. Unpredictable chronic mild stress induced behavioral deficits: a comparative study in male and female rats. Pak J Pharm Sci27(4):879–84.
17.
FriedrichMJ. 2017. Depression is the leading cause of disability around the world. JAMA317(15):1517.
18.
GjerstadJKLightmanSLSpigaF.2018. Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility. Stress21(5):403–16.
19.
HaleemDJ. 1992. Repeated corticosterone treatment attenuates behavioural and neuroendocrine responses to 8-hydroxy-2-(di-n-propylamino) tetralin in rats. Life Sci51(23):PL225–30.
20.
HaleemDJ. 2011. Raphe-hippocampal serotonin neurotransmission in the sex related differences of adaptation to stress: focus on serotonin-1A receptor. Curr Neuropharmacol9(3):512–21.
21.
HaleemDJ. 2016. Drug targets for obesity and depression: from serotonin to leptin. Curr Drug Targets17(11):1282–91.
22.
HaleemDJ. 2017. Improving therapeutics in anorexia nervosa with tryptophan. Life Sci178:87–93.
23.
HaleemDJ. 2018. Serotonin-1A receptor dependent modulation of pain and reward for improving therapy of chronic pain. Pharmacol Res134:212–9.
24.
HaleemDJ. 2019. Targeting serotonin 1a receptors for treating chronic pain and depression. Curr Neuropharmacol17(12):1098–108.
25.
HaleemDJGulS.2020. Circulating leptin, cortisol and gender differences associated with anorexia or obesity in depression. World J Biol Psychiatry21(3):195–202.
26.
HaleemDJKennettGCurzonG.1988. Adaptation of female rats to stress: shift to male pattern by inhibition of corticosterone synthesis. Brain Res458(2):339–47.
27.
HaleemDJKennettGAWhittonPCurzonG.1989. 8-OH-DPAT increases corticosterone but not other 5-HT1A receptor-dependent responses more in females. Eur J Pharmacol164(3):435–43.
28.
HaleemDJSheikhSFawadAHaleemMA. 2017. Fasting leptin and glucose in normal weight, over weight and obese men and women diabetes patients with and without clinical depression. Metab Brain Dis32(3):757–64.
HermanJPFigueiredoHMuellerNKUlrich-LaiYOstranderMMChoiDC, and others. 2003. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol24(3):151–80.
31.
HermanJPMcKlveenJMGhosalSKoppBWulsinAMakinsonR, and others. 2016. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr Physiol6(2):603–21.
32.
HesenWJoëlsM.1996. Modulation of 5HT1A responsiveness in CA1 pyramidal neurons by in vivo activation of corticosteroid receptors. J Neuroendocrinol8(6):433–8.
33.
HlavacovaNJezovaD.2008. Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior. Horm Behav54(1):90–7.
34.
JohnsonMD. 1994. Synaptic glutamate release by postnatal rat serotonergic neurons in microculture. Neuron12(2):433–42.
35.
JudgeSJIngramCDGartsideSE. 2004. GABA receptor modulation of 5-HT neuronal firing: characterization and effect of moderate in vivo variations in glucocorticoid levels. Neurochem Int45(7):1057–65.
36.
KatsurabayashiSKubotaHTokutomiNAkaikeN.2003. A distinct distribution of functional presynaptic 5-HT receptor subtypes on GABAergic nerve terminals projecting to single hippocampal CA1 pyramidal neurons. Neuropharmacology44(8):1022–30.
37.
KellerJGomezRWilliamsGLembkeALazzeroniLMurphyGMJr, and others. 2017. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Mol Psychiatry22(4):527–36.
38.
KennettGADickinsonSLCurzonG.1985a. Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats. Brain Res330(2):253–63.
39.
KennettGADickinsonSLCurzonG.1985b. Central serotonergic responses and behavioural adaptation to repeated immobilisation: the effect of the corticosterone synthesis inhibitor metyrapone. Eur J Pharmacol119(3):143–52.
40.
KimTWLimBVKimKSeoJHKimCJJ. 2015. Treadmill exercise alleviates stress-induced impairment of social interaction through 5-hydroxytryptamine 1A receptor activation in rats. Exerc Rehabil11(4):192–7.
41.
LaarisNLe PoulEHamonMLanfumeyL.1997. Stress-induced alterations of somatodendritic 5-HT1A autoreceptor sensitivity in the rat dorsal raphe nucleus—in vitro electrophysiological evidence. Fundam Clin Pharmacol11(3):206–14.
42.
LanfumeyLPardonMCLaarisNJoubertCHanounNHamonM, and others. 1999. 5-HT1A autoreceptor desensitization by chronic ultramild stress in mice. Neuroreport10(16):3369–74.
43.
LeeSJKimTWParkHKYoonSYouAHMoonEJShinDHChoH. 2016. Postnatal Treadmill Exercise Alleviates Prenatal Stress-Induced Anxiety in Offspring Rats by Enhancing Cell Proliferation Through 5-Hydroxytryptamine 1A Receptor Activation. Int Neurourol J. 20(Suppl 1):S57–64.
44.
LeitchMMIngramCDYoungAHMcQuadeRGartsideSE. 2003. Flattening the corticosterone rhythm attenuates 5-HT1A autoreceptor function in the rat: relevance for depression. Neuropsychopharmacology28(1):119–25.
45.
LiuYSmithLIHuangVPoonVCoelloAOlahM, and others. 2013. Transcriptional regulation of episodic glucocorticoid secretion. Mol Cell Endocrinol371(1–2):62–70.
46.
ManiamJMorrisMJ. 2010. Voluntary exercise and palatable high-fat diet both improve behavioural profile and stress responses in male rats exposed to early life stress: role of hippocampus. Psychoneuroendocrinology35(10):1553–64.
47.
MeijerOCde KloetER. 1994. Corticosterone suppresses the expression of 5-HT1A receptor mRNA in rat dentate gyrus. Eur J Pharmacol266(3):255–61.
48.
MeijerOCWilliamsonADallmanMFPearceDJ. 2000. Transcriptional repression of the 5-HT1A receptor promoter by corticosterone via mineralocorticoid receptors depends on the cellular context. Neuroendocrinology12(3):245–54.
49.
MineurYSEinsteinEBBenthamMPWigestrandMBBlakemanSNewboldSA, and others. 2015. Expression of the 5-HT1A serotonin receptor in the hippocampus is required for social stress resilience and the antidepressant-like effects induced by the nicotinic partial agonist cytisine. Neuropsychopharmacology40(4):938–46.
50.
Mitre-AguilarIBCabrera-QuinteroAJZentella-DehesaA.2015. Genomic and non-genomic effects of glucocorticoids: implications for breast cancer. Int J Clin Exp Pathol8(1):1–10.
51.
OuXMStorringJMKushwahaNAlbertPR. 2001. Heterodimerization of mineralocorticoid and glucocorticoid receptors at a novel negative response element of the 5-HT1A receptor gene. J Biol Chem276(17):14299–307.
52.
PandarakalamJP. 2018. Challenges of treatment-resistant depression. Psychiatr Danub30(3):273–84.
53.
ParkCRosenblatJDBrietzkeEPanZLeeYCaoB, and others. 2019. Stress, epigenetics and depression: a systematic review. Neurosci Biobehav Rev102:139–52.
54.
Richardson-JonesJWCraigeCPGuiardBPStephenAMetzgerKLKungHF, and others. 2010. 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron65(1):40–52.
55.
SakakuraMSaitoYTakebeKIshiiK.1976. Studies on fast feedback mechanisms by endogenous glucocorticoids. Endocrinology98(4):954–7.
56.
SchilkrautJJ. 1965. The catecholamine hypothesis of affective disorder: a review of supporting evidence, Am J Psychiatry122:509–22.
57.
SchmitzDEmpsonRMHeinemannU.1995. Serotonin reduces inhibition via 5-HT1A receptors in area CA1 of rat hippocampal slices in vitro. J Neurosci15(11):7217–25.
58.
SelyeH. 1936. Thymus and adrenals in the response of the organism to injuries and intoxications. Br J Exp Pathol17:234–48.
59.
SullivanPFNealeMCKendlerKS. 2000. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry157(10):1552–62.
60.
TanakaSTsuchidaAKiuchiYOguchiKNumazawaSYoshidaT.2003. GABAergic modulation of hippocampal glutamatergic neurons: an in vivo microdialysis study. Eur J Pharmacol465(1–2):61–7.
61.
TavesMDPlumbAWSandkamBAMaCVan Der GugtenJGHolmesDT, and others. 2015. Steroid profiling reveals widespread local regulation of glucocorticoid levels during mouse development. Endocrinology156(2):511–22.
62.
TimmermansSSouffriauJLibertC.2019. A general introduction to glucocorticoid biology. Front Immunol10:1545.
63.
TongJZhouZQiWJiangSYangBZhongZ, and others. 2019. Antidepressant effect of helicid in chronic unpredictable mild stress model in rats. Int Immunopharmacol67:13–21.
64.
ValdizánEMCastroEPazosA.2010. Agonist-dependent modulation of G-protein coupling and transduction of 5-HT1A receptors in rat dorsal raphe nucleus. Int J Neuropsychopharmacol13(7):835–43.
65.
WangLZhouCZhuDWangXFangLZhongJ, and others. 2016. Serotonin-1A receptor alterations in depression: a meta-analysis of molecular imaging studies. BMC Psychiatry16(1):319.
66.
WissinkSvan der BurgBKatzenellenbogenBSvan der SaagPT. 2001. Synergistic activation of the serotonin-1A receptor by nuclear factor-kappa B and estrogen. Mol Endocrinol15(4):543–52.
67.
YangHThompsonABMcIntoshBJAltieriSCAndrewsAM. 2013. Physiologically relevant changes in serotonin resolved by fast microdialysis. ACS Chem Neurosci4(5):790–8.
